MediFind found 51 doctor with experience in HER-2 Positive Breast Cancer near Baltimore, MD. Of these, 40 are Experienced, 9 are Advanced, 1 are Distinguished and 1 are Elite.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Antonio Wolff is internationally recognized for his work on breast cancer biomarkers, including HER2. As a practicing oncologist and clinical translational researcher, his research has been pivotal to improve the quality of breast cancer biomarker testing in breast cancer, including HER2 and estrogen receptor testing. Among his leadership accomplishments is ensuring that sophisticated laboratory findings are translated into improved clinical care in breast cancer. He is a Fellow of the American Society of Clinical Oncology (ASCO), a Komen Scholar and a Breast Cancer Research Foundation investigator. He has served as associate editor for Journal of Clinical Oncology, and serves on the National Comprehensive Cancer Network (NCCN) Guideline Steering Committee. He is a leader of the Translational Breast Cancer Research Consortium (TBCRC), and one of the principal investigators of the Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies (EVOLVE) in Metastatic Breast Cancer, which was one of the three disease groups recently awarded by ARPA-H to conduct innovative trials using Advanced Analysis for Precision Cancer Therapy (ADAPT). After many years of service as Breast Committee Chair in the ECOG-ACRIN Clinical Trial Network of the National Cancer Institute (NCI), he was elected in 2024 as Co-Chair of the NCI Breast Cancer Steering Committee and appointed to the international steering committee of the Oxford Overview Collaborative, which are positions aimed at advancing clinical trials in breast cancer. At Johns Hopkins, he is an elected member of the Miller Coulson Academy of Clinical Excellence and was honored during the 125th Anniversary Living the Hopkins Mission celebrations of the JHU School of Medicine. Dr. Wolff is rated as an Elite provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Breast Cancer, HER-2 Positive Breast Cancer, Triple-Negative Breast Cancer, and Inflammatory Breast Cancer.
Skip Viragh Outpatient Cancer Center
William Houck is an Oncologist in Baltimore, Maryland. Dr. Houck is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Chronic Lymphocytic Leukemia (CLL).
The Johns Hopkins Hospital
Daniel Zabransky is an Oncologist in Baltimore, Maryland. Dr. Zabransky is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are HER-2 Positive Breast Cancer, Melanoma, Breast Cancer, and Pancreatic Cancer.
St Agnes Healthcare Inc
Noeline Rajarajan is a General Surgeon in Baltimore, Maryland. Dr. Rajarajan is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Breast Lump, and Intraductal Papilloma. Dr. Rajarajan is currently accepting new patients.
St Agnes Healthcare Inc
Kristen Fernandez is a General Surgeon in Baltimore, Maryland. Dr. Fernandez is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Intraductal Papilloma, and Lymphadenectomy. Dr. Fernandez is currently accepting new patients.
Johns Hopkins Bayview Medical Center
Dr. Susan Bahl, MD, FACS, is a distinguished Breast Surgeon who recently joined Johns Hopkins, practicing at both Howard County Medical Center and Johns Hopkins Bayview Medical Center. A strong advocate for women's health, Dr. Bahl brings over a decade of experience in providing state-of-the-art, evidence-based breast care within multidisciplinary settings. She has a passion for delivering personalized treatment plans to patients, specializing in both benign and malignant breast diseases. Before joining Johns Hopkins, Dr. Bahl served as the Medical Director of the Frederick Health Breast Center, where she founded a NAPBC-accredited multidisciplinary breast cancer clinic. In this role, she helped streamline the treatment process for newly diagnosed breast cancer patients by coordinating care between breast surgeons, medical oncologists, and radiation oncologists. Dr. Bahl also co-directed a Breast Screening and Prevention Program designed for high-risk women, integrating genetic testing, risk-reduction surgeries, and chemo-prevention strategies. Her commitment to patient-centered care and leadership in breast health make her a valuable addition to the Johns Hopkins community. Dr. Bahl is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy.
Giuseppe Sanguineti is a Radiation Oncologist in Baltimore, Maryland. Dr. Sanguineti is rated as a Distinguished provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are HER-2 Positive Breast Cancer, Prostate Cancer, Throat Cancer, Prostatectomy, and Hepato-Pancreato-Biliary Surgery.
Johns Hopkins University
Katherine Rappazzo is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Rappazzo has been practicing medicine for over 10 years and is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are HER-2 Positive Breast Cancer, Iron Deficiency Anemia, Childhood Iron Deficiency Anemia, Hodgkin Lymphoma, and Tissue Biopsy.
The Johns Hopkins Hospital
Ravin Garg is a Hematologist Oncology specialist and an Oncologist in Baltimore, Maryland. Dr. Garg is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Large-Cell Immunoblastic Lymphoma, Paget Disease of the Breast, Breast Cancer, and Thrombotic Thrombocytopenic Purpura.
University Of Maryland Medical Center
Elizabeth Nichols is a Radiation Oncologist in Baltimore, Maryland. Dr. Nichols is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Angiosarcoma, Cervical Cancer, and Adult Soft Tissue Sarcoma.
University Of Maryland Radiation Oncology Associates PA
Kamila Choi is a Radiation Oncologist in Baltimore, Maryland. Dr. Choi is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Pleuropulmonary Blastoma, Breast Cancer, Angiosarcoma, and Lung Cancer.
University Of Maryland Radiation Oncology Associates PA
Meredith Wernick is a Radiation Oncologist in Baltimore, Maryland. Dr. Wernick is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Pleuropulmonary Blastoma, Prostate Cancer, and Familial Prostate Cancer. Dr. Wernick is currently accepting new patients.
Roisin Connolly is an Oncologist in Baltimore, Maryland. Dr. Connolly is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, Paget Disease of the Breast, and Tissue Biopsy.
Elizabeth Jaffee is an Oncologist in Baltimore, Maryland. Dr. Jaffee is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Fibrolamellar Carcinoma, Pancreaticoduodenectomy, and Hepato-Pancreato-Biliary Surgery.
Diana Griffiths is an Oncologist in Baltimore, Maryland. Dr. Griffiths is rated as an Advanced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Griffiths is currently accepting new patients.
St Paul Place Specialists, Inc.
Wen Liang is a General Surgeon in Baltimore, Maryland. Dr. Liang is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Paget Disease of the Breast, Breast Cancer, Angiosarcoma, Inflammatory Breast Cancer, and Lymphadenectomy. Dr. Liang is currently accepting new patients.
St Paul Place Specialists, Inc.
Neil Friedman is a General Surgeon in Baltimore, Maryland. Dr. Friedman is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. His top areas of expertise are Breast Cancer, Intraductal Papilloma, Paget Disease of the Breast, Lymphadenectomy, and Mastectomy. Dr. Friedman is currently accepting new patients.
University Of Maryland Surgical Associates PA
Meghan Garstka is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Garstka is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Angiosarcoma, Thyroidectomy, and Lymphadenectomy. Dr. Garstka is currently accepting new patients.
University Of Maryland Oncology Associates PA
Katherine Tkaczuk is an Oncologist in Baltimore, Maryland. Dr. Tkaczuk is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, and Paget Disease of the Breast. Dr. Tkaczuk is currently accepting new patients.
University Of Maryland Surgical Associates PA
Suliat Nurudeen is a Surgical Oncologist and a General Surgeon in Baltimore, Maryland. Dr. Nurudeen is rated as an Experienced provider by MediFind in the treatment of HER-2 Positive Breast Cancer. Her top areas of expertise are Breast Cancer, Fibroadenoma, Giant Mammary Hamartoma, Mastectomy, and Lymphadenectomy. Dr. Nurudeen is currently accepting new patients.
Last Updated: 01/09/2026





